LncRNA MIAT/miR-384-5p在急性心肌梗死大鼠中的作用机制研究

Study on the action mechanism of lncRNA MIAT/miR-384-5p in rats with acute myocardial infarction

  • 摘要:
    目的 探讨抑制lncRNA MIAT对大鼠急性心肌梗死(AMI)的作用及其分子机制。
    方法 将60只雄性SD大鼠随机分为假手术组、AMI组、AMI+si-NC组、AMI+si-MIAT组、AMI+si-MIAT+miR-NC antagomir组、AMI+si-MIAT+miR-384-5p antagomir组。采取心肌原位多点注射的方法转染相应质粒,沉默大鼠lncRNA MIAT和miR-384-5p表达,转染24 h后,结扎心脏左冠状动脉前降支建立AMI模型(缺血24 h)。造模结束,应用生物信号采集系统观测心率(HR)、左心室间隔起搏(LVSP)、左心室舒张末期压(LVEDP)、左心室内压最大上升和下降速率(±dP/dtmax)的变化,TTC染色测量心脏梗死面积,苏木精—伊红(HE)染色观察心肌病理学变化,酶联免疫吸附试验(ELISA)法检测血清心肌钙蛋白Ⅰ(cTn-Ⅰ)含量,透射电镜(TEM)观察自噬小体数量,实时荧光定量PCR(RT-qPCR)检测lncRNA MIAT、miR-384-5p表达,蛋白质免疫印迹(western blotting)法检测自噬相关蛋白Beclin1、Cathepsin D和LC3表达。
    结果 与假手术组相比,lncRNA MIAT在AMI大鼠中的表达上调(P<0.01)。与AMI+si-NC组相比,敲低lncRNA MIAT后miR-384-5p表达上调;大鼠HR、LVSP、+dp/dtmax升高,LVEDP和-dp/dtmax降低,TTC和HE染色显示AMI大鼠心肌梗死面积减小,心肌细胞形态改善,血清cTn-Ⅰ含量降低,自噬小体数量减少,Beclin1、Cathepsin D与LC3蛋白表达水平降低(均P<0.05)。与miR-384-5p拮抗剂合用后,lncRNA MIAT的上述作用被显著逆转(均P<0.05)。
    结论 抑制lncRNA MIAT能减轻AMI大鼠心肌损伤,其作用可能与上调miR-384-5p表达、抑制自噬有关。

     

    Abstract:
    Objective To investigate the role and molecular mechanism of lncRNA MIAT inhibition in acute myocardial infarction (AMI) in rats.
    Methods Sixty male Sprague-Dawley (SD) rats were randomly divided into sham, AMI, AMI+si-NC, AMI+si-MIAT, AMI+si-MIAT+miR-NC antagomir, and AMI+si-MIAT+miR-384-5p antagomir groups. The target plasmids were transfected into the myocardial tissue through in situ multi-point injections to silence the expression of lncRNA MIAT and miR-384-5p in rats. After 24 hours of transfection, the AMI model was established by performing ligation of the left anterior descending branch of the coronary artery of the heart for a duration of 24 hours. After completing the modeling, the changes of heart rate (HR), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP) and the maximum rate of rise and fall of left ventricular pressure (±dP/dtmax) were gauged by biosignal acquisition system. The 2, 3, 5, triphenyl- 2Htetrazolium chloride (TTC) staining was used to determine the infarct size and the pathological changes in cardiomyocytes were observed by hematoxylin-eosin (HE) staining. The level of serum cardiac troponin-Ⅰ (cTn-Ⅰ) was detected by enzyme-linked immunosorbent assay (ELISA). Transmission electron microscope (TEM) was used to observe the number of autophagosomes. Reverse transcription-quantitative polymerase chain reaction (RTqPCR) was used to detect lncRNA MIAT and miR-384-5p gene expression, and western blotting was used to detect autophagy-associated proteins Beclin1, Cathepsin D and LC3 expression.
    Results Compared with the sham group, the expression of lncRNA MIAT was increased in rats with AMI (P < 0.01). Compared with the AMI+siNC group, the knockdown of lncRNA MIAT led to an upregulation of miR-384-5p expression, an increase in the levels of HR, LVSP and +dp/dtmax, and a decrease in the levels of LVEDP and -dp /dtmax. TTC and HE staining revealed a decreased myocardial infarct size in AMI rats and improved cardiomyocyte morphology. Additionally, serum cTn-I levels were significantly reduced, the number of autophagosomes was decreased, and the protein expression levels of Beclin1, Cathepsin D, and LC3 were down-regulated (all P < 0.05). The above effects of lncRNA MIAT knockdown were significantly reversed when co-administered with the miR-384-5p antagomir (all P < 0.05).
    Conclusion Inhibition of lncRNA MIAT can alleviate AMI in rats, which is related to upregulation of miR-384-5p expression and inhibition of autophagy.

     

/

返回文章
返回